Neuroimmunologist Norbert ilka oversees the development of the ACvac1 vaccine at Axon Neuroscience.

Slovak scientists and researchers are developing a vaccine against COVID-19. It is believed it will especially help older people whose bodies find it difficult to elicit an immune response.

Neuroimmunologist NORBERT ILKA, who oversees the development of the vaccine at Axon Neuroscience, explains when the Slovak vaccine could be available and who is financing it.

At what stage of development is the Slovak vaccine ACvac1? Have you tested it on people yet?

No, the vaccine is not yet undergoing clinical trials - the phase in which the vaccine is given to human-volunteers. We are nearing the end of the preclinical phase, which takes place exclusively in the laboratory. Here the vaccine is tested on animals or cultured cells. We are monitoring the potential of the vaccine for its further use.

26. Nov 2020 at 12:01 |Renta Zeln

Excerpt from:
Production of a purely Slovak COVID-19 vaccine to move abroad - The Slovak Spectator